Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges ; volume:127 ; number:4 ; day:26 ; month:3 ; year:2022 ; pages:592-602 ; date:9.2022
British journal of cancer ; 127, Heft 4 (26.3.2022), 592-602, 9.2022
- Creator
-
García-Pardo, Miguel
Makarem, Maisam
Li, Janice J. N.
Kelly, Deirdre
Leighl, Natasha B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-022-01776-9
- URN
-
urn:nbn:de:101:1-2022102603011235705590
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- García-Pardo, Miguel
- Makarem, Maisam
- Li, Janice J. N.
- Kelly, Deirdre
- Leighl, Natasha B.
- SpringerLink (Online service)
Other Objects (12)
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Circulating tumor DNA in Hodgkin lymphoma
Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy
Analyse zellfreier DNA (cfDNA) in liquid biopsies von neuroonkologischen Tumoren
Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Circulating tumor DNA in Hodgkin lymphoma
Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy
Analyse zellfreier DNA (cfDNA) in liquid biopsies von neuroonkologischen Tumoren
Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Circulating tumor DNA in Hodgkin lymphoma
Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy
Analyse zellfreier DNA (cfDNA) in liquid biopsies von neuroonkologischen Tumoren
Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
Cell-free circulating tumor DNA in cancer